Kerry Chrysiliou v B.Braun Melsungen AG

Link copied
Case Copied 31 min read

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Kerry Chrysiliou v B.Braun Melsungen AG [2018] APO 33

Patent Application:                2014240216

Title:Needle Assembly, Safety Catheter Assembly and Method for Assembly

Patent Applicant:                   B.Braun Melsungen AG

Opponent:  Kerry Chrysiliou

Delegate:  Xavier Gisz

Decision Date:  30 May 2018

Hearing Date:  9 March 2018, in Melbourne

Catchwords:  PATENTS - opposition to the grant of the patent under s 59 – opposed on the basis of novelty, inventive step, clarity – all grounds of opposition are unsuccessful – costs awarded against the opponent

Representation:  Counsel for the applicant:  Ed Heerey

Patent attorney for the applicant: Fiona Galbraith of Davies Collison Cave

Thomas Griffiths (by telephone link) of Davies Collison Cave

Kevin Woehr, representative of B. Braun Melsungen AG

Barrister for the opponent:  Ian Horak

Patent attorney for the opponent:  Roger Green and Daniel Bolderston of Watermark

Prabhakar Mani Pratap of Indian attorney firm Vutts & Associates

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                2014240216

Title:Needle Assembly, Safety Catheter Assembly and Method for Assembly

Patent Applicant:                   B.Braun Melsungen AG

Date of Decision:                   30 May 2018

DECISION

The opposition fails on all grounds raised. Subject to appeal, I direct the application proceed to grant. Costs are awarded against the Opponent, Kerry Chrysiliou, according to Schedule 8.

REASONS FOR DECISION

Background

  1. The Applicant (B.Braun Melsungen AG) filed the present Australian Patent Application 2014240216 (the Opposed Application) on 30 September 2014.

  2. The Opposed Application is a divisional application of Australian Patent 2011287917 which was filed as a PCT application (international application number PCT/EP2011/003746) with an international filing date of 26 July 2011 and an earliest priority date of 5 August 2010.

  3. The Opposed Application was published and made open for public inspection on 23 October 2014. The Applicant requested examination of the Opposed Application on 5 December 2014. The Application was accepted by the Commissioner on 29 June 2016 and that acceptance was advertised on 14 July 2016.

  4. On 14 October 2016, Ms Chrysiliou (the Opponent), filed a notice of opposition under section 59 of the Act.

  5. The grounds of opposition were initially set out in the Statement of Grounds and Particulars in Support of Opposition dated 13 January 2017 (SGP). On 22 June 2017, the Opponent submitted a request to file an amended SGP (the amended SGP). The Applicant objected to the amendments in a letter dated 3 July 2017. However, the amendment request was allowed on 21 July 2017

    APPLICABLE LAW

  6. The request for examination of the patent application was filed on 5 December 2014. As a consequence, substantive amendments to the Patents Act brought about by the Intellectual Property Laws Amendment (Raising the Bar) Act 2012 that came into effect on 15 April 2013 apply to the present patent application.

  7. Thus the standard of proof that applies in the present case is the balance of probabilities. I must accept the application if satisfied on the balance of probabilities that the application complies with the Act.  If I am not so satisfied, then I can refuse the application.

    Grounds…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Kerry Chrysiliou v B.Braun Melsungen AG and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2018] APO 33
Decision Date

CaseChat Overview and Summary

The opposition was brought by Ms Chrysiliou against the Applicant B. Braun Melsungen AG in relation to a patent application for a needle assembly, safety catheter assembly and method for assembly. The grounds of opposition were lack of clarity, lack of novelty and lack of inventive step. The court found that the opposition failed on all grounds. The Applicant's patent application was held to be clear, novel and inventive in light of the prior art considered. The court found that the Applicant's patent application disclosed a needle assembly with a needle guard that prevented the needle from slipping out of the safety device when the needle turned or pivoted within the safety device. The court found that the Applicant's invention was not obvious to a person skilled in the art, and that the Applicant had overcome a problem in the prior art by providing a needle guard with an angled end section that was wider than the second free end of the second arm. The court held that the Applicant was entitled to the relief sought in the application and awarded costs against the Opponent.

Background

Background to the litigation

B. Braun Melsungen AG filed an Australian patent application 2014240216 on 30 September 2014 for a needle assembly, safety catheter assembly, and a method for assembly, related to a safety intravenous catheter designed to automatically cover the needle tip after withdrawal to prevent needlestick injuries. The application was a divisional application of Australian Patent 2011287917, originally filed as a PCT application on 26 July 2011 with an earliest priority date of 5 August 2010. On 14 October 2016, Kerry Chrysiliou filed a notice of opposition under section 59 of the Act, opposing the grant of the patent on grounds of lack of clarity, novelty, and inventive step. The opposition was based on several documents, including IN1965/DEL/2009 and EP2016963, as well as prior use of PolySafety versions 1 and 2.

The matter was heard on 9 March 2018 in Melbourne. The Applicant, B. Braun Melsungen AG, was represented by Ed Heerey, Fiona Galbraith of Davies Collison Cave, Thomas Griffiths, and Kevin Woehr. The Opponent, Kerry Chrysiliou, was represented by Ian Horak, Roger Green and Daniel Bolderston of Watermark, and Prabhakar Mani Pratap of Vutts & Associates. The decision was made on 30 May 2018 by Xavier Gisz, Delegate of the Commissioner of Patents, finding the opposition unsuccessful on all grounds and directing the patent application to proceed to grant. Costs were awarded against the Opponent.

Decision

Reasons for decision

Issues
1. Is the Evidence in Reply properly in reply?
2. Is the invention described in the patent application clear?
3. Are the claims of the patent application novel in light of the prior art documents?
4. Do the claims of the patent application involve an inventive step in light of the prior art documents?
5. Was the PolySafety Safety IV Cannula version 2 used publicly before the priority date?
6. Is the invention described in the patent application novel in light of the prior use of PolySafety Safety IV Cannula version 2?
7. Would the person skilled in the art modify the prior art documents such that the second free end of the second arm was narrower than the angled end section?

Held
1. The Evidence in Reply is properly in reply.
2. The invention described in the patent application is clear.
3. The claims of the patent application are novel in light of the prior art documents.
4. The claims of the patent application involve an inventive step in light of the prior art documents.
5. The PolySafety Safety IV Cannula version 2 was not used publicly before the priority date.
6. The invention described in the patent application is novel in light of the prior use of PolySafety Safety IV Cannula version 2.
7. The person skilled in the art would not modify the prior art documents such that the second free end of the second arm was narrower than the angled end section.

Ratio Decidendi

Legal Principle Established

The Commissioner found that the Evidence in Reply was properly in reply, as it responded to evidence presented by the applicant and addressed issues raised by the applicant's expert. The Commissioner held that the invention described in the patent application was clear, as the ambiguity regarding the orientation of length and width in the claims could be resolved by reference to the description. The Commissioner found that the claims were novel in light of the prior art documents, as none of the documents disclosed all the essential features of the invention as claimed. The Commissioner held that the claims involved an inventive step, as there was no information provided to explain the significance of the second arm being narrower than the angled end section, and the potential problems in making such a modification would likely deter a person skilled in the art from making it. The Commissioner found that the PolySafety Safety IV Cannula version 2 was not used publicly before the priority date, as the evidence was insufficient to establish this. The Commissioner held that the invention was novel in light of the prior use of PolySafety Safety IV Cannula version 2, as the version 1 did not add anything of substance over the prior art documents considered. Finally, the Commissioner found that the person skilled in the art would not modify the prior art documents such that the second free end of the second arm was narrower than the angled end section, as there were practical constraints on the variations to dimensions of the free end of the second arm and of the angled end section, and no reasons were provided to suggest that a person skilled in the art would be motivated to make such a modification.

The Commissioner's decision was based on a thorough analysis of the evidence and arguments presented by both parties. The Commissioner considered the plain meaning of the claims, the common general knowledge at the priority date, and the practical constraints on modifying the prior art documents. The Commissioner also considered the significance of the second arm being narrower than the angled end section, and found that there were no reasons to suggest that a person skilled in the art would be motivated to make such a modification. The Commissioner's decision provides clear guidance on the issues raised in the opposition, and sets out the legal principles and authorities relied on in reaching the decision. The ratio decidendi of the decision is that a person skilled in the art would not modify the prior art documents such that the second free end of the second arm was narrower than the angled end section, due to practical constraints and lack of motivation. The Commissioner's decision follows prior authority on the principles of claim construction, clarity, novelty, and inventive step, and does not depart from or distinguish any prior authority.